A rapid systematic review of factors influencing COVID-19 vaccination uptake in minority ethnic groups in the UK

A Kamal, A Hodson, JM Pearce - Vaccines, 2021 - mdpi.com
COVID-19 has disproportionately affected minority ethnic groups in the United Kingdom. To
maximise the effectiveness of the vaccination programme, it is important to understand and …

Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection: a state-of-the-art review

DH Jiang, DJ Roy, BJ Gu, LC Hassett… - Basic to Translational …, 2021 - jacc.org
The vast majority of patients (> 99%) with severe acute respiratory syndrome coronavirus 2
survive immediate infection but remain at risk for persistent and/or delayed multisystem. This …

[HTML][HTML] Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study

C Menni, K Klaser, A May, L Polidori… - The Lancet Infectious …, 2021 - thelancet.com
Summary Background The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca
(ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase …

Covid-19 vaccine hesitancy among ethnic minority groups

MS Razai, T Osama, DGJ McKechnie, A Majeed - bmj, 2021 - bmj.com
With mass covid-19 vaccination efforts under way in many countries, including the UK, we
need to understand and redress the disparities in its uptake. Data to 14 February 2021 show …

Women's views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: a multi-methods study in the UK

H Skirrow, S Barnett, S Bell, L Riaposova… - BMC pregnancy and …, 2022 - Springer
Background COVID-19 vaccines are advised for pregnant women in the United Kingdom
(UK) however COVID-19 vaccine uptake among pregnant women is inadequate. Methods …

Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case …

C Hyams, R Marlow, Z Maseko, J King… - The Lancet Infectious …, 2021 - thelancet.com
Summary Background On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination
authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector …

COVID-19 vaccine hesitancy: the five Cs to tackle behavioural and sociodemographic factors

MS Razai, P Oakeshott, A Esmail… - Journal of the Royal …, 2021 - journals.sagepub.com
The global roll-out of the COVID-19 vaccine is a cause for celebration. Vaccinations are the
most successful public health measure in history, saving millions of lives each year globally …

[HTML][HTML] Strategies and action points to ensure equitable uptake of COVID-19 vaccinations: a national qualitative interview study to explore the views of undocumented …

A Deal, SE Hayward, M Huda, F Knights… - Journal of migration and …, 2021 - Elsevier
Introduction Early evidence confirms lower COVID-19 vaccine uptake in established ethnic
minority populations, yet there has been little focus on understanding vaccine hesitancy and …

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre …

VJ Hall, S Foulkes, A Saei, N Andrews, B Oguti… - The Lancet, 2021 - thelancet.com
Background BNT162b2 mRNA and ChAdOx1 nCOV-19 adenoviral vector vaccines have
been rapidly rolled out in the UK from December, 2020. We aimed to determine the factors …

Trends and clinical characteristics of COVID-19 vaccine recipients: a federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY

HJ Curtis, P Inglesby, CE Morton, B MacKenna… - British Journal of …, 2022 - bjgp.org
Background On 8 December 2020 NHS England administered the first COVID-19
vaccination. Aim To describe trends and variation in vaccine coverage in different clinical …